Nicole Selenko-Gebauer, the Group Vice President and Chief Innovation Officer at Danaher Diagnostics, presented insights at EuroMedLab 2025 regarding the future of diagnostics. She highlighted Danaher's focus on addressing critical needs in neurodegenerative disease diagnosis and enhancing innovation in infectious disease monitoring, paving the way for advancements that can significantly impact patient care.
Newsletters
Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.